Cynosure Lutronic’s XERF Surpasses 2,000 Installations Worldwide, Highlighting Growing Demand for Non-Invasive Skin Tightening Cynosure Lutronic has reached a new commercial milestone for XERF™, its multifrequency monopolar radiofrequency platform for non-invasive structural skin tightening, with the company announcing that the…
Vyriad Reshapes Executive Leadership Team as It Prepares for Next Phase of Growth in In Vivo CAR T and Viral Delivery Therapies Vyriad, Inc., a clinical-stage biotechnology company focused on developing targeted genetic therapies for cancer and other serious diseases,…
Syntax Bio and Ajinomoto Health & Nutrition North America Partner to Evaluate StemFit™ Media for Next-Generation Cell Therapy Workflows Syntax Bio, a synthetic biology company focused on programming the next generation of cell therapies, has entered into a collaboration with…
Neuron23 Secures $2.5 Million Grant from The Michael J. Fox Foundation to Expand Precision Medicine Parkinson’s Trial into Israel Neuron23 Inc., a clinical-stage biotechnology company focused on advancing precision medicine approaches for Parkinson’s disease, has received a $2.5 million grant…
Aleve Launches Project DIY Campaign Featuring Dave and Jenny Marrs to Celebrate Passion Projects and Long-Lasting Pain Relief Aleve®, one of the leading over-the-counter pain relief brands, has unveiled a new consumer marketing initiative called Project DIY, a campaign designed…
Biocytogen’s Boston Research Facility Earns AAALAC International Full Accreditation, Reinforcing Commitment to Scientific Excellence and Animal Welfare Biocytogen has announced a significant achievement for its U.S. research operations, revealing that its Boston research facility has been awarded Full Accreditation by…
Otsuka Completes Acquisition of Transcend Therapeutics to Advance Development of Innovative PTSD Treatment Otsuka America, Inc., a subsidiary of the global healthcare company Otsuka Pharmaceutical Co., Ltd., has completed its acquisition of Transcend Therapeutics, Inc., a biotechnology company focused on…
Cepheid Donates Hemorrhagic Fever Tests to Support Ebola Outbreak Response in Democratic Republic of the Congo and Uganda Cepheid, a molecular diagnostics company and part of Danaher Corporation, has announced the donation of an initial shipment of its Xpert® Hemorrhagic…
Paragon Biosciences Completes Sale of Emalex Biosciences to Teva, Marking Another Milestone in CNS Drug Innovation Paragon Biosciences has announced the successful completion of the sale of Emalex Biosciences to Teva Pharmaceutical Industries, a transaction that highlights Paragon’s strategy of…
LivaNova Strengthens Board Leadership with Appointment of Jette Nygaard-Andersen LivaNova PLC, a global medical technology company focused on developing innovative therapies for patients with neurological and cardiovascular conditions, has announced the election of Jette Nygaard-Andersen to its Board of Directors…
Merck Animal Health to Acquire TARGAN, Expanding Poultry Technology and Biodevice Innovation Capabilities Merck Animal Health, known as MSD Animal Health outside the United States and Canada and operating as a division of Merck & Co., Inc., has announced the…
Vir Biotechnology Appoints Timothy Coughlin to Board of Directors and Audit Committee Leadership Role Vir Biotechnology has announced the appointment of Timothy Coughlin to its Board of Directors, effective June 9, 2026. In addition to joining the board, Coughlin will…